Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer

Table 1 Relationship between clinicopathological characteristics and expression of VPS35, HIF-1α, GLA, CDC37 and SLC7A11 in gastric cancer (n = 63)

	Expression of VPS35		Expression of HIF-1α		Expression of GLA		Expression of CDC37		Expression of SLC7A11
	High (n = 32)	Low (n = 31)	High (n = 32)	Low (n = 31)	High (n = 32)	Low (n = 31)	High (n = 32)	Low (n = 31)	High (n = 32)	Low (n = 31)
Gender
Male	19	23	20	22	22	20	22	20	19	23
Female	13	8	12	9	10	11	10	11	13	8
Age (years)
< 55	5	8	6	7	4	9	6	7	4	9
≥ 55	27	23	26	24	28	22	26	24	28	22
Tumor location
Fundus	7	6	6	7	8	5	7	6	8	5
Body	12	15	16	11	11	16	15	12	15	12
Antrum	13	10	10	13	13	10	10	13	9	14
Tumor size (cm)
≤ 3	17	25	17	25	18	24	19	23	18	24
> 3	15	6*	15	6*	14	7	13	8	14	7
Tumor T stage
1 + 2	20	24	20	24	16	28	21	23	18	26
3 + 4	12	7	12	7	16	3***	11	8	14	5*
Tumor N stage
0	15	19	13	21	13	21	10	24	13	21
1 + 2 + 3	17	12	19	10*	19	10*	22	7***	19	10*
AJCC stage
I + II	21	27	20	28	21	27	20	28	21	27
III	11	4*	12	3**	11	4*	12	3**	11	4*
Differentiation
Well-moderately	11	8	8	11	10	9	11	8	9	10
Poorly	21	23	24	20	22	22	21	23	23	21

Statistical significance was determined by the chi-square test. (*p < 0.05, **p < 0.01)

ISSN: 1475-2867